From Our Perspective
FDA Issues Draft Guidances on Real-World Evidence, Prepares to Publish More in Future
What this series of guidances may mean for industry, healthcare providers, and patients
By John Concato, MD, MPH, MS, Associate Director (Real-World Evidence Analytics), Office of Medical Policy, and M. Khair ElZarrad, PhD, MPH, Director, Office of Medical Policy
More with John Concato, MD, MPH, MS and M. Khair ElZarrad, PhD, MPH
Resources for You